Home › Funds › Hudson Bay Capital Management LP › ABT
Hudson Bay Capital Management LP position in ABT
ABBOTT LABORATORIES · Health Care
Hudson Bay Capital Management LP reported holding 1,500,000 shares of ABT (ABBOTT LABORATORIES) in its Q2 2026 13F filing — a position valued at US$136.1M, representing 0.95% of its reported portfolio and ranking #14 among its reported holdings. Hudson Bay Capital Management LP has disclosed ABT holdings in 7 of the last 9 reported quarters, going back to Q2 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Hudson Bay Capital Management LP's ABT position evolved
Hudson Bay Capital Management LP first disclosed a stake in ABT in Q2 2024 at 45,000 shares (US$4.7M). The position peaked in Q2 2026 at 1,500,000 shares, worth US$136.1M. Across 7 filings, Hudson Bay Capital Management LP increased the stake 4 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 1,500,000 shares valued at US$136.1M — an increase of 1,425,000 shares quarter over quarter.. Notable position changes include a 204% increase in Q2 2025 (shares fell 1% over the following quarter), a 400% increase in Q1 2026 (shares fell 11% over the following quarter), a 1900% increase in Q2 2026 (shares rose 10% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 45.00K | $4.68M | New |
| Q1 2025 | 3.53K | $468.65K | New |
| Q2 2025 | 10.72K | $1.46M | Add |
| Q3 2025 | 5.29K | $707.87K | Reduce |
| Q4 2025 | 15.00K | $1.88M | Add |
| Q1 2026 | 75.00K | $7.70M | Add |
| Q2 2026 | 1.50M | $136.11M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M sh · $5.41B · Q2 2026
- Sixth Street Partners Management Company, L.P. 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital International Investors 34.65M sh · $3.15B · Q2 2026
- Deutsche Bank AG 16.71M sh · $1.52B · Q2 2026
More on Hudson Bay Capital Management LP
FAQ
How long has Hudson Bay Capital Management LP held ABT?
Hudson Bay Capital Management LP has disclosed ABT holdings in 7 of the last 9 reported quarters, going back to Q2 2024.
What is Hudson Bay Capital Management LP's current position in ABT?
As of Q2 2026, Hudson Bay Capital Management LP holds 1.50M shares of ABT (ABBOTT LABORATORIES), valued at $136.11M, representing 0.95% of its reported portfolio and ranking #14.
Has Hudson Bay Capital Management LP been buying or selling ABT?
In the latest 13F filing (Q2 2026), Hudson Bay Capital Management LP increased its position in ABT. The position peaked in Q2 2026 at 1.50M shares.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.